Eli Lilly is investing $1.8 billion across two manufacturing sites in Ireland to boost production of its hugely popular obesity drug and a newly approved treatment for Alzheimer's, the drugmaker said ...
EliLilly (NYSE: LLY) offers investors the same ... through the issuance of additional shares to current holders. The new price depends on the ratio of the split. In recent times, companies ...
Novartis' CDK4/6 inhibitor Kisqali has claimed a broad FDA approval in early breast cancer that could give it an edge over class rival Verzenio from EliLilly ... presented new data from NATALEE ...